-
Proton Pump Inhibitor Use in Infants and Children
PPIs are approved for use in pediatric patients, but these drugs have been associated with some potentially serious adverse effects. Find out what there is to know.
August 22, 2019
-
Dupilumab Use in Moderate-to-Severe Atopic Dermatitis
The recent FDA approval of dupilumab offers another option for the treatment of moderate to severe atopic dermatitis in adolescents.
July 16, 2019
-
Use of Ceftazidime-Avibactam in Infants and Children
Ceftazidime-avibactam is now approved for the treatment of gram-negative bacterial infections in pediatric patients. Find out what there is to know.
June 26, 2019
-
Pediatric Updates From the Food and Drug Administration
Get up-to-date on the latest updates from the FDA regarding potential treatment options for pediatric patients.
June 17, 2019
-
Delayed-Release and Extended-Release Methylphenidate Capsules for Morning Control of Attention-Deficit/Hyperactivity Disorder Symptoms
Newly approved delayed- and extended-release methylphenidate capsules designed for bedtime administration may provide better early morning symptom control for ADHD patients.
May 17, 2019
-
Baloxavir Marboxil: A New Influenza Antiviral With a Novel Mechanism
Baloxavir marboxil is a newly approved treatment for influenza. Learn more about the antiviral mechanism of action of this agent.
April 18, 2019
-
Update on the Use of Tacrolimus in Pediatrics
Tacrolimus is commonly used for the prophylaxis of organ rejection after transplantation. This article provides an update for its use in children.
March 18, 2019
-
Cannabidiol Use in Refractory Epilepsy
The recent FDA approval of cannabidiol provides another treatment option for refractory epilepsy. Find out what there is to know.
February 18, 2019
-
Stiripentol Use in Children With Refractory Seizures
This article summarizes current knowledge regarding the use of stiripentol as an add-on therapy for the treatment of refractory seizures in children.
January 17, 2019
-
Posaconazole Use in Infants and Children
This article provides an update regarding the use of posaconazole for antifungal prophylaxis and treatment in pediatric patients.
December 17, 2018
-
A Reappraisal of Ciprofloxacin Use in Infants and Children
This article provides a reassessment of pediatric ciprofloxacin utilization in light of the recent FDA drug safety communication.
November 16, 2018
-
Update on Levetiracetam in Infants and Children
This article provides an update regarding the use and safety of levetiracetam in the treatment of pediatric epilepsy.
September 17, 2018
-
Fosaprepitant and Aprepitant for Chemotherapy-Induced Nausea and Vomiting in Children
Aprepitant and fosaprepitant have been approved for use in pediatric patients for the prevention of chemotherapy-induced nausea and vomiting.
August 16, 2018
-
Update on the Use of Acetaminophen for Patent Ductus Arteriosus Closure
This article provides an update regarding the use of acetaminophen to close a patent ductus arteriosus.
July 16, 2018
-
News for Pediatric Healthcare Providers From the Food and Drug Administration
Which drugs have been newly developed or indicated for pediatric patients? Find out what there is to know.
June 15, 2018
-
Use of a Third Dose of the Measles Mumps Rubella Vaccine During Mumps Outbreaks
Could the administration of a third dose of the MMR vaccine add an additional layer of protection during mumps outbreaks?
May 16, 2018
-
Treatment of Status Epilepticus
What are the latest therapeutic options for status epilepticus?
April 02, 2018
-
Drug Fever: Recent Cases From the Medical Literature
A review of recent case reports provides insight into the symptoms of drug fever and the agents that have been associated with this condition.
February 14, 2018
-
Extended-Release Methylphenidate Orally Disintegrating Tablets
A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.
December 05, 2017
-
New Drug Approvals and New Pediatric Indications
Which drugs are newly indicated for use in pediatric patients? This article provides an update.
November 28, 2017
